Literature DB >> 25589306

Effect of ischemic postconditioning on myocardial salvage in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the POST randomized trial.

Eun Kyoung Kim1, Joo-Yong Hahn, Young Bin Song, Sang-Chol Lee, Jin-Ho Choi, Seung-Hyuk Choi, Sang Hoon Lee, Yeon Hyeon Choe, Hyeon-Cheol Gwon.   

Abstract

In the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) trial, ischemic postconditioning did not improve myocardial reperfusion in 700 patients with STEMI undergoing primary PCI. However, the impact of postconditioning on myocardial salvage and infarct size still needs to be addressed. The aim of this study was to investigate the effect of ischemic postconditioning on myocardial salvage using cardiac magnetic resonance (CMR) in patients with STEMI undergoing primary PCI. For the CMR substudy, a total of 111 patients was analyzed, 56 in the postconditioning group and 55 undergoing conventional primary PCI in the control group. Postconditioning was performed immediately after restoration of coronary flow by four cycles of 1-min balloon occlusion separated by 1 min of deflation. The primary end point was myocardial salvage measured by CMR 3 days after the index event. The myocardial salvage index was not improved by ischemic postconditioning compared with conventional PCI (46.3 ± 18.5 vs. 45.7 ± 20.5%, p = 0.86). The infarct size was not significantly different between the two groups (18.8 ± 10.3 vs. 20.2 ± 11.0%, p = 0.52). Moreover, there was no significant difference in the rates of microvascular obstruction or hemorrhagic infarction between the groups. CMR study demonstrated that ischemic postconditioning during primary PCI in STEMI patients did not improve myocardial salvage or reduce infarct size. These findings further support the results of the POST trial which showed no benefit of ischemic postconditioning as an adjunctive treatment of primary PCI.

Entities:  

Mesh:

Year:  2015        PMID: 25589306     DOI: 10.1007/s10554-015-0589-y

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  25 in total

1.  Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.

Authors:  Jacob Lønborg; Henning Kelbaek; Niels Vejlstrup; Erik Jørgensen; Steffen Helqvist; Kari Saunamäki; Peter Clemmensen; Lene Holmvang; Marek Treiman; Jan S Jensen; Thomas Engstrøm
Journal:  Circ Cardiovasc Interv       Date:  2010-01-26       Impact factor: 6.546

2.  Postconditioning the human heart in percutaneous coronary intervention.

Authors:  Feng Xue; Xiangjun Yang; Bing Zhang; Caiming Zhao; Jianping Song; Tingbo Jiang; Wenping Jiang
Journal:  Clin Cardiol       Date:  2010-07       Impact factor: 2.882

3.  Upstream high-dose tirofiban does not reduce myocardial infarct size in patients undergoing primary percutaneous coronary intervention: a magnetic resonance imaging pilot study.

Authors:  Young Bin Song; Joo-Yong Hahn; Hyeon-Cheol Gwon; Jun Hyung Kim; Sang Yeub Lee; Yeon Hyeon Choe; Seung-Hyuk Choi; Jin-Ho Choi; Sang Hoon Lee
Journal:  Clin Cardiol       Date:  2009-06       Impact factor: 2.882

4.  Relationship between ST-segment resolution and anterior infarct size after primary percutaneous coronary intervention: analysis from the INFUSE-AMI trial.

Authors:  José M Dizon; Sorin J Brener; Akiko Maehara; Bernard Witzenbichler; Angelo Biviano; Jacek Godlewski; Helen Parise; Jan-Henk Dambrink; Roxana Mehran; C Michael Gibson; Gregg W Stone
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-10-03

5.  Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

Authors:  A W van 't Hof; A Liem; M J de Boer; F Zijlstra
Journal:  Lancet       Date:  1997-08-30       Impact factor: 79.321

6.  Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial.

Authors:  Giuseppe Tarantini; Enrico Favaretto; Martina Perazzolo Marra; Anna Chiara Frigo; Massimo Napodano; Luisa Cacciavillani; Andrea Giovagnoni; Pietro Renda; Valeria De Biasio; Mario Plebani; Monica Mion; Martina Zaninotto; Giambattista Isabella; Claudio Bilato; Sabino Iliceto
Journal:  Int J Cardiol       Date:  2012-04-09       Impact factor: 4.164

7.  Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.

Authors:  Zhi-Qing Zhao; Joel S Corvera; Michael E Halkos; Faraz Kerendi; Ning-Ping Wang; Robert A Guyton; Jakob Vinten-Johansen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08       Impact factor: 4.733

8.  Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.

Authors:  Sorin J Brener; Akiko Maehara; Jose M Dizon; Martin Fahy; Bernhard Witzenbichler; Helen Parise; Magdi El-Omar; Jan-Henk Dambrink; Roxana Mehran; Keith Oldroyd; C Michael Gibson; Gregg W Stone
Journal:  JACC Cardiovasc Interv       Date:  2013-07       Impact factor: 11.195

9.  Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.

Authors:  Javier Ganame; Giancarlo Messalli; Steven Dymarkowski; Frank E Rademakers; Walter Desmet; Frans Van de Werf; Jan Bogaert
Journal:  Eur Heart J       Date:  2009-04-03       Impact factor: 29.983

10.  Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group.

Authors:  A W van 't Hof; A Liem; H Suryapranata; J C Hoorntje; M J de Boer; F Zijlstra
Journal:  Circulation       Date:  1998-06-16       Impact factor: 29.690

View more
  10 in total

Review 1.  Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery.

Authors:  Derek J Hausenloy; Jose A Barrabes; Hans Erik Bøtker; Sean M Davidson; Fabio Di Lisa; James Downey; Thomas Engstrom; Péter Ferdinandy; Hector A Carbrera-Fuentes; Gerd Heusch; Borja Ibanez; Efstathios K Iliodromitis; Javier Inserte; Robert Jennings; Neena Kalia; Rajesh Kharbanda; Sandrine Lecour; Michael Marber; Tetsuji Miura; Michel Ovize; Miguel A Perez-Pinzon; Hans Michael Piper; Karin Przyklenk; Michael Rahbek Schmidt; Andrew Redington; Marisol Ruiz-Meana; Gemma Vilahur; Jakob Vinten-Johansen; Derek M Yellon; David Garcia-Dorado
Journal:  Basic Res Cardiol       Date:  2016-10-20       Impact factor: 17.165

2.  In vivo MRI and ex vivo histological assessment of the cardioprotection induced by ischemic preconditioning, postconditioning and remote conditioning in a closed-chest porcine model of reperfused acute myocardial infarction: importance of microvasculature.

Authors:  Tamás Baranyai; Zoltán Giricz; Zoltán V Varga; Gábor Koncsos; Dominika Lukovic; András Makkos; Márta Sárközy; Noémi Pávó; András Jakab; Csilla Czimbalmos; Hajnalka Vágó; Zoltán Ruzsa; Levente Tóth; Rita Garamvölgyi; Béla Merkely; Rainer Schulz; Mariann Gyöngyösi; Péter Ferdinandy
Journal:  J Transl Med       Date:  2017-04-01       Impact factor: 5.531

3.  Morphine Does Not Affect Myocardial Salvage in ST-Segment Elevation Myocardial Infarction.

Authors:  Hye Bin Gwag; Taek Kyu Park; Young Bin Song; Eun Kyoung Kim; Woo Jin Jang; Jeong Hoon Yang; Joo-Yong Hahn; Seung-Hyuk Choi; Jin-Ho Choi; Sang Hoon Lee; Yeon Hyeon Choe; Joonghyun Ahn; Keumhee Chough Carriere; Hyeon-Cheol Gwon
Journal:  PLoS One       Date:  2017-01-12       Impact factor: 3.240

4.  Ischemic postconditioning reduces infarct size and microvascular obstruction zone in acute ST-elevation myocardial infarction - a randomized study.

Authors:  Aleksander Araszkiewicz; Marek Grygier; Małgorzta Pyda; Justyna Rajewska; Michał Michalak; Sylwia Sławek-Szmyt; Maciej Lesiak
Journal:  Postepy Kardiol Interwencyjnej       Date:  2019-09-18       Impact factor: 1.426

Review 5.  Ischemia Reperfusion Injury: Mechanisms of Damage/Protection and Novel Strategies for Cardiac Recovery/Regeneration.

Authors:  Andrea Caccioppo; Luca Franchin; Alberto Grosso; Filippo Angelini; Fabrizio D'Ascenzo; Maria Felice Brizzi
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

6.  Comparison of infarction size, complete ST-segment resolution incidence, mortality and re-infarction and target vessel revascularization between remote ischemic conditioning and ischemic postconditioning in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention.

Authors:  Haozhou Zhang; Lei Yang; Lei Wang
Journal:  Postepy Kardiol Interwencyjnej       Date:  2020-10-02       Impact factor: 1.426

7.  A randomized controlled clinical trial of prolonged balloon inflation during stent deployment strategy in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a pilot study.

Authors:  Min Ma; Ling Wang; Kai-Yue Diao; Shi-Chu Liang; Ye Zhu; Hua Wang; Mian Wang; Li Zhang; Zhi-Gang Yang; Yong He
Journal:  BMC Cardiovasc Disord       Date:  2022-02-04       Impact factor: 2.298

8.  Ischemic Preconditioning and Postconditioning Protect the Heart by Preserving the Mitochondrial Network.

Authors:  Nur Izzah Ismail; Nathaly Anto Michel; Khairunnisa Katwadi; Mim-Mim Lim; To-Kiu Chan; Attaur Rahman; Dachun Xu; Sang-Ging Ong; Derek J Hausenloy; Sang-Bing Ong
Journal:  Biomed Res Int       Date:  2022-09-27       Impact factor: 3.246

Review 9.  Ischaemic conditioning and reperfusion injury.

Authors:  Derek J Hausenloy; Derek M Yellon
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

10.  Meta-analysis of the effects of ischemic postconditioning on structural pathology in ST-segment elevation acute myocardial infarction.

Authors:  Baohui Lou; Yadong Cui; Haiyang Gao; Min Chen
Journal:  Oncotarget       Date:  2017-12-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.